Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...

Ozempic is traditionally used as a treatment for type 2 diabetes (T2DM) to help patients manage blood sugar levels. However, ...

Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

It said “public interest in the use of GLP-1RA products for weight loss is high” and they are an effective treatment for ...

In a discovery study, investigators generated an atlas of associations with GLP-1RA initiation versus use of sulfonylureas, dipeptidyl peptidase 4 (DPP4) inhibitors and sodium-glucose cotransporter-2 ...

A recent commentary article published in Diabetes, Metabolic Syndrome and Obesity provides dietary recommendations for ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Medicine Weight ...

EVA Pharma of Africa, DNA Script and Quantoom Biosciences have signed a MoU to establish the mRNA production platform in Egypt.

Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard ...